Success Metrics

Clinical Success Rate
96.2%

Based on 25 completed trials

Completion Rate
96%(25/26)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Terminated
1(4%)

Phase Distribution

Ph phase_3
4
15%
Ph phase_1
20
77%
Ph phase_2
2
8%

Phase Distribution

20

Early Stage

2

Mid Stage

4

Late Stage

Phase Distribution26 total trials
Phase 1Safety & dosage
20(76.9%)
Phase 2Efficacy & side effects
2(7.7%)
Phase 3Large-scale testing
4(15.4%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

96.2%

25 of 26 finished

Non-Completion Rate

3.8%

1 ended early

Currently Active

0

trials recruiting

Total Trials

26

all time

Status Distribution
Completed(25)
Terminated(1)

Detailed Status

Completed25
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
26
Active
0
Success Rate
96.2%
Most Advanced
Phase 3

Trials by Phase

Phase 120 (76.9%)
Phase 22 (7.7%)
Phase 34 (15.4%)

Trials by Status

completed2596%
terminated14%

Recent Activity

Clinical Trials (26)

Showing 20 of 26 trialsScroll for more
NCT01316094Phase 3

A Study to Assess Efficacy and Safety of ASP1941 in Diabetic Patients With Renal Impairment

Completed
NCT00790660Phase 2

A Study to Assess the Safety and Tolerability of ASP1941 in Adults With Type 2 Diabetes Mellitus.

Completed
NCT01505426Phase 3

A Study to Assess the Efficacy and Safety of ASP1941 in Combination With Metformin in Asian Diabetes Patients

Completed
NCT01023945Phase 1

A Study of ASP1941 in Japanese Patients With Type 2 Diabetes Mellitus

Completed
NCT02529449Phase 2

Pharmacodynamics, Pharmacokinetics, and Safety of ASP1941 in Patients With Type 1 Diabetes Mellitus

Completed
NCT01514838Phase 3

A Study to Assess the Efficacy and Safety of ASP1941 in Asian Subjects With Type 2 Diabetes Mellitus

Terminated
NCT01097681Phase 1

A Study to Assess the Pharmacokinetics, Pharmacodynamics of ASP1941 in Diabetes Mellitus Patients With Renal Impairment

Completed
NCT02452632Phase 3

A Study to Assess the Efficacy and Safety of ASP1941 in Subjects With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Metformin and Sitagliptin

Completed
NCT01611363Phase 1

A Phase 1 Study to Investigate the Mechanism of Action of Ipragliflozin

Completed
NCT01302028Phase 1

Renal Impairment Study With ASP1941

Completed
NCT01302145Phase 1

Drug to Drug Interaction Study With ASP1941 and Metformin

Completed
NCT01972880Phase 1

A Study to Compare the Oral Absorption of ASP1941 Among Two Types of Tablets

Completed
NCT01678287Phase 1

Study of the Pharmacokinetics of ASP1941 and the Effect on Glucose Concentrations in Male and Female Young and Elderly Healthy Adults

Completed
NCT01674777Phase 1

A Study to Investigate the Effect of Food on the Absorption, Distribution and Elimination of ASP1941

Completed
NCT01403818Phase 1

A Study to Assess the Effect of ASP1941 and Mitiglinide on Their Plasma Concentration

Completed
NCT01373060Phase 1

A Study to Assess the Safety, Pharmacokinetics and Pharmacodynamics of ASP1941 in Healthy Male Taiwanese Subjects

Completed
NCT01232413Phase 1

A Study of the Effect of ASP1941 on Cardiac Repolarization in Healthy Subjects

Completed
NCT01302132Phase 1

Mass Balance Study of ASP1941

Completed
NCT01302158Phase 1

Drug-drug Interaction Study With ASP1941 and Glimepiride

Completed
NCT01288898Phase 1

Multiple Dose Escalating Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ASP1941

Completed

Drug Details

Intervention Type
DRUG
Total Trials
26